Stocks
Daiichi Sankyo Company, LimitedDSKYF
OTCHealthcareBiotechnology$17.53-2.61%
A global pharmaceutical company focused on researching, developing, and commercializing innovative medicines, particularly in oncology and rare diseases. Investors monitor its pipeline of antibody-drug conjugates and strategic partnerships with Western drugmakers.
Market Cap: $32.4B52W Range: $16.81 – $29.15
Congressional Interest in Daiichi Sankyo Company, Limited (DSKYF)
3 members of Congress have disclosed 3 trades in Daiichi Sankyo Company, Limited (DSKYF), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
3
Buys
1
Sells
2
Who in Congress Is Trading DSKYF?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-07-03 | Gilbert Cisneros | sell | $1K – $15K |
| 2019-04-04 | David P. Roe | buy | $1K – $15K |